📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones ( PATCH ) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer (2016)

First Author: Gilbert D

Attributed to: CANCER: Trials with potential global reach and other challenging trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bju.13687

PubMed Identifier: 27753182

Publication URI: http://europepmc.org/abstract/MED/27753182

Type: Journal Article/Review

Parent Publication: BJU International

Issue: 5

ISSN: 1464-4096